ARTICLE | Clinical News
Abemaciclib: Final Ph II neoMONARCH data
January 27, 2017 4:31 AM UTC
Final data from the open-label, international Phase II neoMONARCH trial in 224 postmenopausal women with previously untreated, early stage hormone receptor-positive, HER2-negative breast cancer showed...
BCIQ Company Profiles